Your Article Summary
See Latest ArticlesOlanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues
Neuropsychiatric Disease and Treatment, 07/02/09
Bobo WV et al. - While effective during acute-phase treatment, questions remain regarding the long-term efficacy and safety of FLX/OLZ relative to antidepressant monotherapy and other combination strategies. Efforts aimed at determining the placement of FLX/OLZ among the available options for addressing TRD are limited by lack of comparison and sequential treatment studies. Important aspects of study design and directions for future research are discussed.
Methods- In each study, the FLX/OLZ combination caused rapid reduction in Montgomery-Asberg Depression Rating scale scores, with two of the four studies showing significantly greater improvement than antidepressant monotherapy at study endpoint.
- Effects of the FLX/OLZ combination were strongest in cases where failure to respond to two antidepressants prior to randomization was established during the current depressive episode.
- The FLX/OLZ combination was well-tolerated; however, body weight gain and increases in prolactin were greater than that of the antidepressant monotherapy groups, and were comparable to that of OLZ monotherapy.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Review: erythropoiesis-stimulating agents increase mortality in patients with cancer
Evidence-Based Medicine, 12/07/09
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
What drives referral from primary care physicians to mental health specialists? A randomized trial using actors portraying depressive symptoms
Journal of General Internal Medicine, 12/07/09
Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients
Journal of General Internal Medicine, 12/07/09
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
Schizophrenia Research, 12/07/09